FTC opens investigation into Teva, escalating patent fight with pharma industry – The Washington Post
Business News
- FTC opens investigation into Teva, escalating patent fight with pharma industry The Washington Post
- Teva Pharmaceutical to Face FTC Investigation Over Patents Bloomberg
- Teva’s stock falls after report FTC has opened probe of patents MarketWatch
- Teva focus of FTC investigation over inhaler patents (NYSE:TEVA) Seeking Alpha
- After months of warnings, FTC opens investigation into Teva over ‘improper’ patents STAT
Source: Business News